Clorox: Your Steady Investment in an Unsteady World
Understanding Clorox's Recent Market Performance and Future Prospects
In recent years, investors in Clorox have experienced a downturn in their holdings, with a significant decline in value over the past five years, even considering dividend payouts. However, the focus for astute investors shifts from past performance to future potential. This analysis explores why Clorox's period of difficulty may be subsiding and highlights its position as a premier high-yield dividend stock for acquisition this August.
Strategic Expansion: The Integration of Purell into Clorox's Portfolio
A pivotal development for Clorox was the acquisition of Gojo Industries on April 1, which brought the renowned Purell brand under its umbrella. This strategic move significantly strengthens Clorox's health and hygiene division, which now accounts for over half of the company's total net sales and is a primary catalyst for overall sales growth. Projections for fiscal year 2027 indicate a substantial 13% to 14% increase in net sales, with the Purell acquisition alone contributing a significant 9.5% to this forecast, alongside an expected 3.5% to 4.5% organic sales growth. Consequently, adjusted earnings per share are anticipated to rise by 3% to 8%, reaching an estimated $5.70 to $6.00.
Navigating Headwinds: Operational Reforms and Market Dynamics
The upcoming fiscal year will mark the first full operational period following Clorox's comprehensive enterprise resource planning (ERP) system overhaul, which concluded in February. Although this $580 million project faced delays and exceeded budget, it is designed to streamline various business functions, including finance, supply chain, and sales, through a new cloud-based infrastructure. Clorox has been contending with persistent challenges such as post-pandemic supply chain disruptions, inflationary pressures, and a costly cyberattack in August 2023. While the company is transitioning from a phase of stabilization to optimization, management has expressed a cautious outlook on consumer spending, anticipating continued value-consciousness, which could temper category growth and intensify competition.
Sustaining Shareholder Returns: The Strength of Clorox's Dividend
On July 31, Clorox modestly increased its quarterly dividend from $1.24 to $1.25 per share. This measured approach reflects the company's commitment to maintaining an affordable payout while extending its remarkable streak of consecutive dividend increases to 49 years. Clorox anticipates robust free cash flow generation in fiscal 2027, projecting 11%-13% of net sales, which, based on an estimated $7.63 billion in net sales, would amount to approximately $915 million in free cash flow. This strong cash generation comfortably covers the projected $625 million in dividend payments, underscoring the sustainability of its attractive 5.1% yield.
A Prudent Choice: Clorox as a Premier Value and Income Investment
Clorox stands out as an exceptional value stock for investors in August, particularly those seeking to augment their retirement income. The company is on the cusp of becoming a 'Dividend King' in 2027, a designation reserved for companies with at least 50 consecutive years of dividend increases, joining an elite group of only 57 companies as of July 2. With its closing price of $98.26 per share on August 3, Clorox trades at a mere 16.8 times the midpoint of its fiscal 2027 earnings per share guidance of $5.85. This valuation is notably low for a company boasting leading brands across diverse product categories. While it may not offer the rapid growth associated with high-octane stocks, Clorox presents a deep value proposition, making it an ideal choice for long-term income-oriented investors.
